Genomic Confidence

Some oncologists are rather gung-ho about using multiplex genomic tests and ready to use them to evaluate tumors and develop treatments for most of their patients, but others are much more wary about these gadgets, a new study finds.

The survey results, published in the Journal of Clinical Oncology, suggests there is "wide variation" in attitudes among cancer doctors about using multiplex tests to hunt for hundreds of variations in tumors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Not Yet Sure

Just Another Test

Very Own Mouse

This Week in Science

The Pair of Them

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.